Serving 500+ biopharmaceutical companies globally:

Deloitte
McKesson
AstraZeneca
Fish and Richardson
Medtronic
Moodys
Novartis
Teva
UBS
Baxter

Global Biologic and Pharmaceutical Business Intelligence With Simple Flat-Rate Pricing
15,614 international drug patents are set to expire next year

 Most Comprehensive  Most Popular

Forecasting

$ 2700/3 months
Designed for short-term projects
$ 7995/year
25% savings over three-month plan
Inquire about site licenses or API access

Patents Plus

$ 1350/3 months
Designed for short-term projects
$ 3995/year
25% savings over three-month plan
Inquire about site licenses or API access

Core Data

$ 1000/3 months
Designed for short-term projects
$ 2995/year
25% savings over three-month plan
Inquire about site licenses or API access
US & International Patent Data US & International Patent Data US Patent Data
Detailed Regulatory Status Detailed Regulatory Status Detailed Regulatory Status
Email Alerts and Data Export Email Alerts and Data Export Email Alerts and Data Export
Expired Patents Expired Patents -
Non-Orange Book Patents Non-Orange Book Patents -
Finished Product Suppliers Finished Product Suppliers -
Bulk API Vendors - -
Patent Applications - -
Clinical Trials - -
Optional add-ons for all plans
Biologic Drug Patents: $1995 inquire
Multiple Users: 70% discount inquire

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Pick Your Plan

 Most Popular  Most Comprehensive
Feature Forecasting Plan Patents Plus Core Data
Patents
Detailed Patent Information
International Patent Data -
Supplementary Protection Certificates (SPCs) -
Non-Orange Book Patents -
Expired Patents (1986 - Present) -
Patent Applications
Abandoned Patents - -
Pending Patent Applications - -
Granted Patent Applications - -
Patent Maintenance - -
Clinical Trials
Target Diseases - -
Trial Locations - -
Trial Progress - -
Trial Sponsors - -
Regulatory
Detailed Regulatory Status
Paragraph IV Challenges
Tentative Approvals (first generic entrants)
Drug Master File Listings
Authorized Generics -
Drug Information
Comprehensive Drug Information
Drug Class
Suppliers -
Bulk API Vendors - -
Manufacturing - -
Additional Features
Email Alerts
Data Export
Dynamic Trend Graphs
Price / Year $7995 $3995 $2995
► INSTANT ACCESS
Inquire about site licenses
► INSTANT ACCESS
Inquire about site licenses
► INSTANT ACCESS
Inquire about site licenses

Frequently Asked Questions

DrugPatentWatch has patent coverage for the following countries and regional organizations:

African Intellectual Property Organization (OAPI) African Regional IP Organization (ARIPO) Algeria Argentina Australia Austria Bahrain (GCC) Belgium Benin (OAPI) Bosnia and Herzegovina Botswana (ARIPO) Brazil Bulgaria Burkina Faso (OAPI) Cameroon (OAPI) Canada Central African Republic (OAPI) Chad (OAPI) Chile China Colombia Comoros (OAPI) Congo-Brazzaville (OAPI) Costa Rica Croatia Cuba Cyprus Czech Republic Czechoslovakia Côte d'Ivoire (OAPI) Denmark Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea (OAPI) Estonia Eurasian Patent Organization European Patent Office Finland France Gabon (OAPI) Georgia, Republic of German Democratic Republic Germany Ghana (ARIPO) Greece Guatemala Guinea (OAPI) Guinea-Bissau (OAPI) Gulf Cooperation Council Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Jordan Kenya (ARIPO) Kuwait (GCC) Latvia Lesotho (ARIPO) Liberia (ARIPO) Lithuania Luxembourg Malawi (ARIPO) Malaysia Mali (OAPI) Mauritania (OAPI) Mexico Moldova, Republic of Monaco Montenegro Morocco Mozambique (ARIPO) Namibia (ARIPO) Netherlands New Zealand Nicaragua Niger (OAPI) Norway Oman (GCC) Panama Peru Philippines Poland Portugal Qatar (GCC) Romania Russian Federation Rwanda (ARIPO) San Marino Saudi Arabia Saudi Arabia (GCC) Senegal (OAPI) Serbia Sierra Leone (ARIPO) Singapore Slovakia Slovenia Somalia (ARIPO) South Africa South Korea Spain Sudan (ARIPO) Swaziland (ARIPO) Sweden Switzerland São Tomé and Príncipe (ARIPO) Taiwan Tajikistan Tanzania (ARIPO) The Gambia (ARIPO) Togo (OAPI) Tunisia Turkey Uganda (ARIPO) Ukraine United Arab Emirates (GCC) United Kingdom United States of America Uruguay Viet Nam Yugoslavia Zambia (ARIPO) Zimbabwe (ARIPO)

Adding an alert is as easy as clicking the 'Add Alert' button on a page of interest.

    Available alerts include:

  • Paragraph IV challenges
  • New drugs and added or expired patents per company
  • Added or expired patents per drug
  • Tentative approvals

Enterprise Plans are available for unlimited users within your organization. The other plans cannot be shared, but multiple accounts can be purchased for a substantial discount. For more information on enterprise plans, please contact us

Please use the contact form and tell us which subscription plan you would like an invoice for.

No problem. Please use the contact form and let us know how we can be of assistance.

Clients in 54 Countries

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Drugs.com Fortune- Generics' new legal attack: Big Pharma's aging patents CNN Money - Generics' new legal attack: Big Pharma's aging patents New England Journal of Medicine Barrons

Globalization of Pharmaceutical Drug Innovation The structure and business of biopharmaceutical companies including the management of risks and resources Drug Topics Nature Biotechnology Cardinal Health Business Insider National Bureau of Economic Research

botpot